authors
- Hijazi, Ziad
- Hohnloser, Stefan H
- Oldgren, Jonas
- Andersson, Ulrika
- Connolly, Stuart
- Eikelboom, John
- Ezekowitz, Michael D
- Reilly, Paul A
- Yusuf, Salim
- Wallentin, Lars
Efficacy and safety of dabigatran compared with warfarin in patients with atrial fibrillation in relation to renal function over time—A RE-LY trial analysis
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- April 2018
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- 1117 Public Health and Health Services (FoR)
- Aged (MeSH)
- Anticoagulants (MeSH)
- Atrial Fibrillation (MeSH)
- Cardiovascular System & Hematology (Science Metrix)
- Cause of Death (MeSH)
- Dabigatran (MeSH)
- Double-Blind Method (MeSH)
- Female (MeSH)
- Follow-Up Studies (MeSH)
- Glomerular Filtration Rate (MeSH)
- Humans (MeSH)
- Internationality (MeSH)
- Kaplan-Meier Estimate (MeSH)
- Kidney Function Tests (MeSH)
- Male (MeSH)
- Middle Aged (MeSH)
- Proportional Hazards Models (MeSH)
- Risk Assessment (MeSH)
- Stroke (MeSH)
- Survival Analysis (MeSH)
- Time Factors (MeSH)
- Treatment Outcome (MeSH)
- Warfarin (MeSH)
published in
- American Heart Journal Journal